Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600 E/K mutated malignant melanomas
Abstract Patients with metastasized malignant melanomas (MM) are regularly treated with immune checkpoint inhibitors (CPI). Within our study, we evaluated the predictive value of tumor infiltrating lymphocyte (TIL) clusters in primary MM and its association to molecular subtypes to predict response...
Guardado en:
Autores principales: | Sebastian Klein, Cornelia Mauch, Klaus Brinker, Ka-Won Noh, Sonja Knez, Reinhard Büttner, Alexander Quaas, Doris Helbig |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3199c96a9b2944c8a2c270cc0d8bd80c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma
por: Tang HC, et al.
Publicado: (2015) -
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.
por: Adriana Cordova, et al.
Publicado: (2012) -
Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
por: Zaharie F, et al.
Publicado: (2015) -
Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
por: Shujing Liu, et al.
Publicado: (2018) -
Author Correction: Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
por: Shujing Liu, et al.
Publicado: (2019)